HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Kajiyama Selected Research

nartograstim

1/2021Nested Case-Control Study Utilizing MID-NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Kajiyama Research Topics

Disease

1Thrombocytopenia (Thrombopenia)
01/2021
1Stroke (Strokes)
01/2019
1Heart Failure
01/2019
1Myocardial Infarction
01/2019
1Hyperlipidemias (Hyperlipidemia)
07/2015

Drug/Important Bio-Agent (IBA)

1nartograstimIBA
01/2021
1pegfilgrastim (Neulasta)FDA Link
01/2021
1Filgrastim (Neupogen)FDA Link
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1LenograstimIBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1BiguanidesIBA
01/2019
1GlucosidasesIBA
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
07/2015
1Olanzapine (Zyprexa)FDA Link
07/2015
1antiarrhythmic peptide (AAP)IBA
07/2015